{"nct_id":"NCT04799353","title":"Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2021-03-15","start_date_type":"ACTUAL","primary_completion_date":"2022-10-11","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}